RETRA hydrochlorideCat No. 3214 |
Price and Availability |
|
Chemical Name: 2-[(4,5-Dihydro-2-thiazolyl)thio]-1-(3,4-dihydroxypheny l)ethanone hydrochloride |
|
Biological Activity
Antitumor agent. Inhibits tumor cell growth in a mutant p53- and p73-dependent manner in vitro and in vivo (IC50 = 4 μM). Transcriptionally activates expression of p53-responsive genes and induces activation of effector caspases 3 and 7.Technical Data
M.Wt:The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis and MSDS.
Resources
Certificate of Analysis / MSDS
References
Kravchenko et al (2008) Small-molecule RETRA suppresses mutant p53-bearing cancer cells through a p73-dependent salvage pathway. Proc.Natl.Acad.Sci.USA 105 6302.If you know of a useful citation for this product please let us know.
Keywords: RETRA hydrochloride, Antitumor, agent, suppresses, mutant, p53-bearing, Transcription, Factors, p73
Buy Now / Print Quote
Find multiple products by catalog number
Print Quote Facility
Order via your purchasing department
It's now even easier to place orders via your purchasing department.
Simply add a product to your cart & click on the "Print Quote" button.
Signal Transduction Guide
A collection of more than 600 products for signal transduction research. View PDF today.
Cancer Research Guide
Highlights over 400 products for cancer research. Request a copy or view PDF today.
VEGF Pathway & Anti-Angiogenic Therapy
Written by N. Ferrara & Y. Crawford
A summary of antiangiogenic therapies targeting the VEGF pathway and the mechanisms of therapy resistance.
New Products in this Area
Hdm2 inhibitor; activates p53-dependent transcription
SJ 172550MDMX inhibitor. Disrupts MDMX-p53 interaction
INH1Hec1 inhibitor; causes arrest of mitosis
Cyclic Pifithrin-α hydrobromidep53 inhibitor
RSS News Feed
Find out about new products as soon as they go live!
Click on the orange RSS button to read more about our RSS feed and actively opt in.